| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2022 | Liu Joy | SVP, General Counsel | Sell | 36 | $300.32 | $10,811.52 | -0.3% | +3.6% | +17.4% | |
| Aug 9, 2022 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 1,400 | $298.97 | $418,556.74 | -0.6% | +1.5% | +15.5% | |
| Aug 9, 2022 | Liu Joy | SVP, General Counsel | Sell | 946 | $300.00 | $283,800.00 | -6.6% | +1.5% | +15.5% | |
| Aug 9, 2022 | Arbuckle Stuart A | EVP, COO | Sale+OE | 5,690 | $300.67 | $1,710,816.70 | -4.4% | +1.5% | +15.5% | |
| Aug 8, 2022 | Bhatia Sangeeta N.48 | Director | Sell | 621 | $293.03 | $181,971.89 | -2.5% | +3.2% | +17.2% | |
| Aug 8, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sale+OE | 1,304 | $292.54 | $381,469.38 | -0.7% | +3.2% | +17.2% | |
| Jul 29, 2022 | Bhatia Sangeeta N.48 | Director | Sell | 621 | $278.77 | $173,116.37 | -1.9% | +2.7% | +26.3% | |
| Jul 25, 2022 | Leiden Jeffrey M47 | Executive Chairman | Sale+OE | 132,079 | $281.38 | $37,164,480.57 | -32.3% | +9.5% | +26.2% | |
| Jul 19, 2022 | Altshuler David48 | EVP, Global Research And CSO | Sale+OE | 17,865 | $288.65 | $5,156,729.70 | -9.0% | +2.6% | +23.8% | |
| Jun 24, 2022 | Kewalramani Reshma55 | CEO &President | Sell | 11,689 | $291.30 | $3,405,005.70 | -9.5% | -2.1% | +18.6% |